MedPath

Passiflora incarnata flower

Generic Name
Passiflora incarnata flower
Drug Type
Biotech
Unique Ingredient Identifier
SY49TH8VUA

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

  • Anxiety Acute
  • Irritability
  • Nervousness
  • Sleep disorders and disturbances
  • Stress, Mental

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2018/12/19
Phase 4
UNKNOWN
Nutricion Medica S.L.
2014/02/19
Phase 2
Completed
Universidade Federal de Sergipe
2012/08/15
Phase 3
Completed
Pascoe Pharmazeutische Praeparate GmbH

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
King Bio Inc.
57955-9003
ORAL
10 [hp_X] in 59 mL
5/19/2025
King Bio Inc.
57955-9005
ORAL
10 [hp_X] in 59 mL
5/19/2025
Hyland's Inc.
54973-3257
ORAL
4 [hp_X] in 1 1
4/9/2025
King Bio Inc.
57955-9004
ORAL
10 [hp_X] in 59 mL
5/19/2025
King Bio Inc.
57955-5638
ORAL
10 [hp_X] in 59 mL
5/19/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
PASSIFLORA GRANULE 1DH
homeocan inc.
00859435
Tablet - Oral
1 DH / DH
12/31/1989
LAPIDAR 7 TAB
swiss herbal remedies ltd.
00445347
Tablet - Oral
3.5 MG
12/31/1976
ISOPT
terra botanica products ltd.
02233339
Liquid - Oral
30 X
6/3/1998
UNDA 228
seroyal international inc.
02233241
Granules ,  Liquid ,  Pellet ,  Drops ,  Tablet - Oral
4 X
4/6/1998
PASSIFLORA GOUTTE 1DH-30CH
boiron laboratoires
00669962
Drops - Oral
1 DH / DH
12/31/1987
PASSIFLORA INCARNATA
seroyal international inc.
02233185
Drops ,  Pellet ,  Granules ,  Globules ,  Tablet ,  Liquid - Oral
1 X
4/6/1998
NERVOSITE - CAP 230MG
laboratoire lalco inc.
02228041
Capsule - Oral
230 MG / CAP
1/20/1997
THC COMPLEX #71
total health centre
02236390
Drops - Oral
1 X
3/29/1998
NEUPLEX
bio active canada ltd.
02233658
Liquid - Oral
3 X
5/26/1998
MEDIPLEX 670 - LIQ
mediherb inc.
02116839
Liquid - Oral
2 X / ML
12/19/1996

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.